Neil G. Snowise

INTREPID: single-<i>versus</i>multiple-inhaler triple therapy for COPD in usual clinical practice

David Halpin, Sally Worsley, Afisi Ismaila et al. · ERJ Open Research · 2021 · 63 citations · Full text

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

Ashley Woodcock, Eugene R. Bleecker, Jan Lötvall et al. · Respiratory Research · 2011 · 45 citations · Full text

Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting

David Halpin, Kieran Rothnie, Victoria Banks et al. · International Journal of COPD · 2022 · 44 citations · Full text

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

Ashley Woodcock, Eric D. Bateman, Jan Lötvall et al. · Respiratory Research · 2011 · 42 citations · Full text

Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial

Richard K. Sterling, Jessica Lim, Lucy Frith et al. · Respiratory Medicine · 2012 · 30 citations · Full text

Asthma, Allergy, Long-acting Beta2 Agonist +8